The Early Toxicology of Physostigmine: A Tale of Beans, Great Men and Egos

ISSN： 1176-2551

Source： Adverse Drug Reactions & Toxicological Reviews (now known as Toxicological Reviews), Vol.25, Iss.2, 2006-01, pp. : 99-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Medical Economic Fairy Tale: Jack, the Magic Beans, Medicare and the US FDA

By Nusbaum Neil J.

Drugs & Aging, Vol. 23, Iss. 6, 2006-01 ,pp. : 447-450

Adis International

Access to resources Recommend Favorite

The role of investigative molecular toxicology in early stage drug development

By Gross Cindy J Kramer Jeffrey A

Expert Opinion on Drug Safety, Vol. 2, Iss. 2, 2003-03 ,pp. : 147-159

Informa Healthcare

Access to resources Recommend Favorite

The role of early in vivo toxicity testing in drug discovery toxicology

By Fielden Mark R Kolaja Kyle L

Expert Opinion on Drug Safety, Vol. 7, Iss. 2, 2008-03 ,pp. : 107-110

Informa Healthcare

Access to resources Recommend Favorite

Overtreatment of men with early-stage prostate cancer and limited life expectancy

Cancer, Vol. 120, Iss. 23, 2014-12 ,pp. : 3592-3594

Blackwell Publishing

Access to resources Recommend Favorite

Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine

By Zhao Q. Tang X.C.

European Journal of Pharmacology, Vol. 455, Iss. 2, 2002-11 ,pp. : 101-107

Elsevier

Access to resources Recommend Favorite